Select a Region North America

洞察

Insights From Our Experts

Articles

Q&A: Enhanced Protection and Consistency for PRCI in Canada

Introduction At EVERSANA, we’re at the forefront of regulatory work in Canada, and recently, our team has been delving into the realm of PRCI (Public Release of Clinical Information) in  Canada and submission Policy 0070 (Regulation…

The Looming Legacy of Software as a Medical Device (SaMD) Misclassification Under Medical Device Directive (MDD)

Regulation (EU) 2017/745, the Medical Device Regulation (MDR), sent shockwaves through the industry with its stricter oversight and transparency demands. While the implementation challenges like delays, notified body capacity, and EUDAMED implementation have dominated discussions, a…

Navigating Successful Partnerships in the Pharmaceutical Industry: Insights from Shorla Oncology CEO Sharon Cunningham

In the ever-evolving landscape of the pharmaceutical industry, forging successful partnerships and collaborations is a cornerstone of achieving groundbreaking advancements and bringing innovative treatments to patients in need. However, navigating through the myriad of advisors, consultants…

Excel in Market Access Success: Key Considerations for Leveraging Your Evidence

Introduction The landscape of launching new medical products presents significant challenges, with a staggering 66% of launches falling short of consensus expectations. Half of these failures are attributed directly to poor market access. Recognizing this, companies…

Measuring Willingness to Pay: The Next Access Frontier

EVERSANA’s APAC Team Authors: Robin Arnold, Swapnil Waichale, Lakshmi Pragna Kalavacharla, Utkarsh Sahu Patient access to expensive healthcare poses a significant challenge in the pharmaceutical industry. As the cost of developing innovative medicines rises, the demand…

Navigating the Patient Journey: Understanding, Challenges, and Solutions in Patient Journey Mapping

EVERSANA’s APAC Authors: Ankit Kulshrestha, Robin Arnold  This POV explores the intricacies of Patient Journey Mapping, detailing its significance, challenges, and solutions. Patient journey mapping is a comprehensive discipline that traces a patient’s entire healthcare journey, from…

Empowering Success: EVERSANA’s Value & Evidence Team Guides Clients Through CMS Drug Negotiations Under the Inflation Reduction Act

Authors: Chris Cameron, Kerise Clarke, Barkha Patel, Amanda Griffin In anticipation of CMS’s announcement of the first 10 drugs to be selected for negotiations through the Inflation Reduction Act on September 1, 2023, we partnered to…

CES 2024 Recap – How the Future of Healthcare Will Continue to Be Driven By Innovation & AI

CES 2024, the annual tech conference encompassing everything from cutting-edge gadgets to automotive marvels, healthcare innovations, and futuristic media, left a lasting impression. Amidst the buzz surrounding electric vehicles, transparent screens, and an abundance of massage…

Redefining Field Deployment – Bridging “Share of Voice” with “Share of Influence” for Lasting Impact

In the dynamic realm of pharmaceutical marketing, sales representatives and television commercials remain go-to strategies, skillfully weaving narratives that assure patients of a brand’s therapeutic benefits and persuade providers to alter prescribing habits. Despite their effectiveness,…

Uncovering Health Disparities: Exploring Social Determinants of Metastatic Prostate Cancer Survival

Author(s): Imtiaz A. Samjoo, MSc, PhD; Emily Rosta, MSc; Austin Lansing, MSc; Alexandra Hall, MPH Despite recent advancements in metastatic prostate cancer (mPC) treatment, prevention and care, progress has not equally manifested in all population groups.…